An intravenous vaccine, manufactured from autologous dendritic cells, for the treatment of metastatic androgen-independent prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous vaccine, manufactured from autologous dendritic cells, for the treatment of metastatic androgen-independent prostate cancer.
If you have a Hayes login, click here to view the full report on the Knowledge Center.